| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | CEO | Director
2 companies
Troendle August J. serves as a President &CEO at MEDP and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 19 buys and 231 sells. Those positions are worth an estimated $381.5M at current prices.
Historically, Troendle August J.'s trades have earned a strong insider score of 70/100 across 164 rated trades. Over a 12-month horizon, 79.5% of those trades were profitable, with an average 12-month return of +13.1%.
The biggest single holding is MEDP (~$381.4M) as President &CEO. The recent filings there lean toward selling, a net 4,402,326 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2018 | MEDP Medpace Holdings, Inc. | President &CEO | Sell | 132,304 | $58.58 | $7,750,265.96 | -0.5% | |
| Sep 21, 2018 | MEDP Medpace Holdings, Inc. | President &CEO | Sell | 2,713 | $58.47 | $158,629.11 | - | |
| Sep 20, 2018 | MEDP Medpace Holdings, Inc. | President &CEO | Sell | 114,983 | $59.31 | $6,819,138.38 | -0.6% | |
| Aug 7, 2018 | MEDP Medpace Holdings, Inc. | President &CEO | Sell | 138,105 | $57.06 | $7,880,271.30 | -28.2% | |
| Aug 6, 2018 | MEDP Medpace Holdings, Inc. | President &CEO | Sell | 731,460 | $59.26 | $43,344,976.43 | -26.9% | |
| Aug 18, 2016 | MEDP Medpace Holdings, Inc. | President &CEO | Buy | 10,000 | $27.98 | $279,800.00 | New | |
| Aug 16, 2016 | MEDP Medpace Holdings, Inc. | President &CEO | Buy | 869,565 | $23.00 | $19,999,995.00 | +247.1% | |
| Jul 30, 2015 | CHRS Coherus Oncology, Inc. | Director | Sell | 340,000 | $33.84 | $11,504,563.68 | -4.0% | |
| Jun 15, 2015 | CHRS Coherus Oncology, Inc. | Director | Sell | 250,000 | $26.68 | $6,670,677.65 | -3.1% |